Serotonin Imbalance Isn't Just a Chemical Problem. It's Written in Your Genes.

COMT (catechol-O-methyltransferase) is an enzyme that degrades dopamine, norepinephrine, and epinephrine. These aren’t just mood molecules; they’re your stress response hormones. When COMT is working well, it keeps your stress hormones at a healthy level and then clears them when the threat has passed. This keeps your nervous system in balance: alert when necessary, calm when safe.

About 25% of people with European ancestry carry the Val158Met variant homozygously, meaning they inherited the slow version from both parents. In these individuals, stress hormones clear 25-40% more slowly from the brain, creating a persistent state of elevated alertness and emotional reactivity. Where a fast COMT person might feel stressed for 20 minutes and then calm down, a slow COMT person can feel the stress lingering for hours or days.

The lived experience: You feel wired after conflict or caffeine. Your nervous system takes a long time to downregulate. Anxiety feels like a constant hum. You’re sensitive to stimulation, crowds, or unexpected changes. SSRIs don’t always help because the problem isn’t serotonin alone; it’s that your dopamine and norepinephrine are stuck in overdrive, keeping your threat-detection system permanently switched on.

SLC6A4 encodes the serotonin transporter, the protein that reabsorbs serotonin from the synapse (the gap between neurons) and recycles it back into the neuron so it can be used again. Without efficient recycling, serotonin gets used up, and your brain has less available to regulate mood, sleep, and impulse control.

The 5-HTTLPR short allele variant is carried by roughly 40% of the population. People with the short/short genotype have approximately 40-50% fewer serotonin transporters in their synapses. This means serotonin released during mood regulation or stress doesn’t get recycled efficiently, depleting your available serotonin pool. Over time, your brain downregulates its serotonin receptors as a compensation, making the system even less responsive.

The lived experience: You feel emotionally fragile. Small stressors feel overwhelming. Your mood is reactive and hard to stabilize. SSRIs make sense theoretically (they block the transporter, keeping serotonin in the synapse longer), but some people with this variant feel the benefit plateaus quickly, or they develop tolerance. Sleep is often poor because serotonin regulates sleep-wake cycles. Anxiety shows up as anticipatory worry rather than panic.

TPH2 (tryptophan hydroxylase 2) catalyzes the very first step of serotonin synthesis in the brain: converting the amino acid tryptophan into 5-hydroxytryptophan (5-HTP), which is then converted into serotonin. This is the rate-limiting step. No matter how much tryptophan you eat, if TPH2 activity is low, your brain won’t synthesize serotonin efficiently.

Variants in TPH2 are carried by roughly 20% of the population and reduce TPH2 enzyme activity by 20-40%, directly lowering your brain’s serotonin synthesis capacity. This means your baseline serotonin production is genetically constrained. You can’t supplement your way out of this; you can only work with what you’ve got and maximize the precursors available.

The lived experience: You have a baseline low mood that doesn’t respond fully to lifestyle changes. Sunlight, exercise, and social connection help, but there’s a ceiling. Sleep tends to be poor because serotonin drives melatonin production. Seasonal mood changes are pronounced. SSRIs may help, but your response is often modest because the medication is working with a reduced substrate (less baseline serotonin to accumulate).

MAOA (monoamine oxidase A) degrades serotonin, dopamine, and norepinephrine after they’ve done their job in the synapse. It’s the brain’s cleanup enzyme. When MAOA works at normal speed, neurotransmitters are available long enough to do their job, then cleared. When MAOA is slow, neurotransmitters linger, which can be calming but also dysregulating if levels get too high.

The MAOA-L (low activity) variant is carried by roughly 30-40% of males and reduces MAOA enzyme activity by 40-60%, allowing neurotransmitters to accumulate and linger longer in the synapse. This can feel good in low-stress situations (you feel naturally calm and focused), but in high-stress situations, neurotransmitter levels can spike unpredictably, causing emotional intensity, impulsivity, or anger. Some research links MAOA-L to greater stress reactivity and mood volatility.

The lived experience: Your mood can swing quickly depending on context. Under pressure, you might become irritable or emotionally explosive. Calm situations feel great. You may be sensitive to serotonergic drugs (SSRIs) because they push serotonin levels even higher. Some people with MAOA-L feel significantly better on lower SSRI doses or respond better to non-pharmacological mood support.

GAD1 encodes glutamic acid decarboxylase 1, an enzyme that converts glutamate (excitatory) into GABA (inhibitory). GABA is your brain’s natural brake pedal. When GABA is flowing, you feel calm and grounded. When GABA is low, your nervous system stays in a state of excitation, and anxiety becomes the default.

Variants in GAD1 are present in roughly 20-30% of the population and reduce GAD1 enzyme activity, lowering your brain’s GABA production and tilting your nervous system toward excitation rather than inhibition. The result is a baseline anxiety state: your nervous system is harder to settle. Meditation helps temporarily, but you keep returning to a state of hypervigilance.

The lived experience: You’re naturally anxious. Relaxation doesn’t come easily. Your thoughts race. You startle easily. Sleep onset is hard because your brain won’t quiet down. Caffeine makes you severely jittery. SSRIs help somewhat because serotonin has some inhibitory effects, but they don’t fully address the GABA deficit. You often feel like you’re thinking too much.

MTHFR (methylenetetrahydrofolate reductase) catalyzes a critical step in the methylation cycle. Methylation is the process that attaches methyl groups to molecules, and it’s required for the synthesis of serotonin, dopamine, norepinephrine, and other mood-regulating molecules. It also affects gene expression, detoxification, and immune function. MTHFR is central to brain chemistry.

The C677T variant is carried by roughly 40% of people with European ancestry and reduces MTHFR enzyme activity by 40-70%, impairing your ability to methylate molecules and synthesize neurotransmitters. Even if you eat enough tryptophan or take B vitamins, your cells may lack the methylated folate they need to actually convert those substrates into working serotonin, dopamine, and norepinephrine.

The lived experience: You feel brain fog alongside mood symptoms. Your mood is low or flat. You have low energy. You might feel worse on standard B vitamins (which require methylation to be activated). You may have other methylation-dependent issues: chemical sensitivities, slow detoxification, or slow stress recovery. SSRIs may help, but your baseline still feels depleted. You often wonder if you’re actually depressed or just running on empty at the biochemical level.